Fundamentals-based quality & risk · not a recommendation
M K Proteins Ltd scores 55/100 (Watch) on the Orion Score — weak business quality (43), strong growth (78) and moderate balance-sheet safety (58). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
34/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Q3 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q3 2026 | ₹89.56 | ₹1.43 | 2.5% | ₹0.04 |
| Q2 2026 | ₹32.43 | ₹0.75 | 2.9% | ₹0.02 |
| Q1 2026 | ₹114.95 | ₹3.51 | 4.7% | ₹0.09 |
| Q4 2025 | ₹137.2 | ₹2.8 | 3.4% | — |
| Q3 2025 | ₹39.48 | ₹1.38 | 4.3% | ₹0.04 |
Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2025 | ₹267.71 | ₹8.4 | ₹12.91 | 4.5% |
| FY 2024 | ₹245.57 | ₹11.21 | ₹17.06 | 6.7% |
| FY 2023 | ₹314.86 | ₹10.93 | ₹17.65 | 5.3% |
| FY 2022 | ₹255.89 | ₹10.18 | ₹15.79 | 5.8% |
Top companies in the same sector by market cap
| Company | Mkt Cap | P/E | ROCE | ROE | D/E | OPM |
|---|---|---|---|---|---|---|
| MKPL ★ | — | 27.39 | 17.03% | — | 0.03x | 2.51% |
| HINDUNILVR | ₹4,98,466 Cr | 46.95 | 21.37% | 21.60% | 0.03x | 21.55% |
| BRITANNIA | ₹1,30,370 Cr | 51.47 | 57.77% | 53.31% | 0.27x | 16.38% |
| COLPAL | ₹55,550 Cr | 40.99 | 103.69% | 81.59% | 0.03x | 29.98% |
| AWL | ₹24,400 Cr | 23.44 | 15.16% | 10.52% | 0.11x | 1.84% |
| CCL | ₹15,885 Cr | 41.00 | 20.46% | 18.00% | 0.56x | 12.36% |
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹130.57 | ₹96.25 | ₹103.22 | ₹85.09 |
| Equity | ₹69.47 | ₹61.08 | ₹49.86 | ₹38.9 |
| Total Debt | ₹38.72 | ₹20.08 | ₹45.53 | ₹37.79 |
| Cash | ₹0.03 | ₹0.09 | ₹0.06 | ₹0.01 |
| Net Debt | ₹37.72 | ₹19 | ₹44.46 | ₹36.78 |
| Working Capital | ₹59.51 | ₹51.87 | ₹48.95 | ₹37.65 |
Q1 FY2027
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q1 FY2027 | 74.82% | 0% | 0% | 25.18% |
| Q3 FY2026 | 74.82% | 0% | — | 25.18% |
| Q2 FY2026 | 74.82% | 0% | — | 25.17% |
| Q1 FY2026 | 74.82% | 0% | — | 25.18% |
| Q4 FY2025 | 74.82% | 0% | — | 25.17% |
| Q3 FY2025 | 74.82% ↓ | 0% | — | 25.18% |
| Q2 FY2025 | 74.83% | 0% ↓ | — | 25.17% ↑ |
| Q1 FY2025 | 74.83% | 0.02% | — | 25.15% |
No recent corporate actions
Ask: "Is M K Proteins Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.
M K Proteins Ltd is listed on the NSE under the Fast Moving Consumer Goods sector, Edible Oil industry. ISIN: INE964W01021. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.